Evaluating risk detection methods to uncover ontogenic-mediated adverse drug effect mechanisms in children.

Our study underscores the opportunity for using population modeling techniques, which leverage drug event reporting across development stages, as biologically-inspired detection methods for evaluating ontogenic mechanisms.